Home » Newsletters » BioWorld

BioWorld

Nov. 12, 1991

View Archived Issues

IDEXX ACQUIRES TEST MANUFACTURER

PHARMATEC CLOSES ON FINANCING

IMMUNOMEDICS SEEKS EUROPEAN APPROVAL

MOLECULAR MARKETS NON-INVASIVE DETECTOR

COLLABORATION FOR LYME DISEASE VACCINE

CELGENE FILES FOR OFFERING

BROCADES TO MARKET LIDAKOL IN EUROPE

ORPHAN DESIGNATION FOR SHOCK ADJUNCT

NICOTINE PATCHES: NOT JUST BLOWING SMOKE

COMPETITION NOT FAZED BY SYSTEMIX PATENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...